Significantly lower tumour-to-blood ratios were observed with excess unlabelled ATG-101 or anti-PD-L1 antibodies (Fig. 5b and d), further confirming specific binding of [89Zr]Zr-Df-ATG-101 to PD-L1. The gene discussed is CD274; the disease is neoplasm.